Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 7/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2471296 | 0.82 | ACHE (0.43) | CA1CA2ACHEMAPTKDM4E | |
| SCHEMBL11214731 | 0.82 | PTPN1 (0.46) | CA1CA2MAPTKDM4EMEN1 | |
| SCHEMBL3123767 | 0.80 | PTPN1 (0.44) | CA1CA2ACHEMAPTKDM4E | |
| SCHEMBL86951 | 0.80 | CA1 (0.42) | CA1CA2ACHEMAPTKDM4E | |
| SCHEMBL21757390 | 0.80 | ACHE (0.42) | CA1CA2ACHEMAPTKDM4E | |
| SCHEMBL2051242 | 0.80 | CA1 (0.42) | CA1CA2MAPTKDM4EMEN1 | |
| SCHEMBL21883741 | 0.78 | ACHE (0.50) | CA1CA2ACHEMAPTKDM4E | |
| SCHEMBL4950394 | 0.78 | MAPT (0.36) | CA1CA2ACHEMAPTKDM4E | |
| SCHEMBL658795 | 0.77 | ACHE (0.43) | CA1CA2ACHEMAPTKDM4E | |
| SCHEMBL24803322 | 0.76 | ALDH1A1 (0.50) | ACHEMAPTKDM4ELMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7038067-B2 | Process for synthesizing d-tocotrienols from 2-vinylchromane compound | YASOO HEALTH, INC. (US) | 2006-05-02 | — | — | US | claimed |
| US-20050124688-A1 | Process for synthesizing d-tocotrienols from 2-vinylchromane compound | YASOO HEALTH, INC. | 2005-06-09 | — | — | US | claimed |
| US-20050124687-A1 | Process for synthesizing d-tocotrienols | COULADOUROS ELIAS A (GR) | 2005-06-09 | — | — | US | claimed |
| WO-2005035491-A2 | PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS FROM 2- VINYLCHROMANE COMPOUND | YASOO HEALTH, INC. (US) | 2005-04-21 | — | — | WO | claimed |
| WO-2005035490-A2 | PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS | YASOO HEALTH, INC. (US) | 2005-04-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124688-A1 | Process for synthesizing d-tocotrienols from 2-vinylchromane compound | FDFT1, DHCR7, DDT | CA1 3703/4885CA2 4376/4885ACHE 3541/4885 |
| US-20050124687-A1 | Process for synthesizing d-tocotrienols | UGT8, DDOST, GGPS1 | CA1 4581/4885CA2 4668/4885ACHE 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.